Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 13,677.33 802.58 196.25 -222.32 30.62 0.00 17.5254 -0.40 -1.0105 -23.1639 -0.09 -0.08 7.7016 - -
Maximum - - - - - - 465,034.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
UCB SA UCBJF 194.76 0.00 0.00% 0 vs. 0 36,949.00 2,663.00 32.00 311.00 6,578.00 0.1700 116.8303 0.0000 0.6211 0.0120 0.0036 0.0021 0.8062 189.00
Melexis NV MLXSF 74.25 0.00 0.00% 1 vs. 0 2,999.00 241.00 52.00 9.00 606.00 1.3100 19.6403 0.0000 0.4416 0.2190 0.0880 0.0593 1.5735 40.00
Galapagos NV GLPGF 24.55 0.00 0.00% 0 vs. 0 1,617.00 62.00 90.00 -124.00 -133.00 1.3700 4.4516 0.0000 0.9592 1.4451 0.0312 0.0207 9.5496 65.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for ARGX.BR and its peers to uncover potential buy and sell opportunities.